Home » Stocks » CYRX

CryoPort, Inc. (CYRX)

Stock Price: $63.03 USD 1.47 (2.39%)
Updated May 7, 2021 4:00 PM EDT - Market closed
Market Cap 2.87B
Revenue (ttm) 122.21M
Net Income (ttm) -76.81M
Shares Out 45.60M
EPS (ttm) -1.91
PE Ratio n/a
Forward PE 666.67
Dividend n/a
Dividend Yield n/a
Trading Day May 7
Last Price $63.03
Previous Close $61.56
Change ($) 1.47
Change (%) 2.39%
Day's Open 62.57
Day's Range 61.76 - 65.50
Day's Volume 324,904
52-Week Range 20.21 - 84.97

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

CryoPort, Inc. (CYRX) delivered earnings and revenue surprises of 38.10% and 13.63%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

4 days ago - Zacks Investment Research

NASHVILLE, Tenn., May 4, 2021 /PRNewswire/ -- Cryoport, Inc. (NASDAQ: CYRX) ("Cryoport" or the "Company"), a global leader in temperature-controlled supply chain solutions for the life sciences industry...

4 days ago - PRNewsWire

NASHVILLE, Tenn., April 27, 2021 /PRNewswire/ -- Cryoport, Inc. (NASDAQ: CYRX) ("Cryoport" or the "Company"), a global leader in temperature-controlled supply chain solutions for the life sciences indus...

1 week ago - PRNewsWire

New York, New York--(Newsfile Corp. - April 8, 2021) - Levi & Korsinsky announces it has commenced an investigation of Cryoport, Inc. (NASDAQ: CYRX) concerning possible breaches of fiduciary duty. To ob...

1 month ago - Newsfile Corp

NASHVILLE, Tenn., April 6, 2021 /PRNewswire/ -- Cryoport, Inc. (NASDAQ: CYRX) ("Cryoport" or the "Company"), a global leader in temperature-controlled supply chain solutions for the life sciences indust...

1 month ago - PRNewsWire

The stock price of CryoPort, a provider of cold chain logistics solutions for biopharmaceutical companies, has seen a large 22% drop over the last five trading days, but we believe the stock, after the ...

1 month ago - Forbes

NASHVILLE, Tenn., March 3, 2021 /PRNewswire/ -- Cryoport, Inc. (NASDAQ: CYRX) ("Cryoport" or the "Company"), a global leader in temperature-controlled supply chain solutions for the life sciences indust...

2 months ago - PRNewsWire

CryoPort, Inc. (CYRX) delivered earnings and revenue surprises of -86.67% and 11.71%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?

2 months ago - Zacks Investment Research

NASHVILLE, Tenn., March 1, 2021 /PRNewswire/ -- Cryoport, Inc. (NASDAQ: CYRX) ("Cryoport" or the "Company"), a global leader in temperature-controlled supply chain solutions for the life sciences indust...

2 months ago - PRNewsWire

NASHVILLE, Tenn., Feb. 25, 2021 /PRNewswire/ -- Cryoport, Inc. (NASDAQ: CYRX) ("Cryoport" or the "Company"), a global leader in temperature-controlled supply chain solutions for the life sciences indust...

2 months ago - PRNewsWire

NASHVILLE, Tenn., Feb. 25, 2021 /PRNewswire/ -- Cryoport, Inc. (NASDAQ: CYRX) ("Cryoport" or the "Company"), a global leader in temperature-controlled supply chain solutions for the life sciences indust...

2 months ago - PRNewsWire

NASHVILLE, Tenn., Jan. 25, 2021 /PRNewswire/ -- Cryoport, Inc. (Nasdaq: CYRX) ("Cryoport" or the "Company"), a global leader in temperature-controlled supply chain solutions for the life sciences indust...

3 months ago - PRNewsWire

NASHVILLE, Tenn., Jan. 20, 2021 /PRNewswire/ -- Cryoport, Inc. (Nasdaq: CYRX) ("Cryoport" or the "Company"), a global leader in temperature-controlled supply chain solutions for the life sciences indust...

3 months ago - PRNewsWire

NASHVILLE, Tenn., Jan. 19, 2021 /PRNewswire/ -- Cryoport, Inc. (Nasdaq: CYRX) ("Cryoport" or the "Company"), a global leader in temperature-controlled supply chain solutions for the life sciences indust...

3 months ago - PRNewsWire

Both stocks are in the early stage of a long-term growth trajectory.

Other stocks mentioned: BCRX
4 months ago - The Motley Fool

Where investors are putting money to work in the Covid vaccine supply chain

YouTube video

CNBC's "Halftime Report" team is joined by Kate Kelly of The New York Times to discuss where investors are putting money along the vaccine supply chain, including cold storage.

4 months ago - CNBC Television

With the approval of Yescarta and Kymriah in recent years, you are now seeing unprecedented growth in the CAR-T industry. Logistic providers that support CAR-T and gene therapies are profiting from this...

5 months ago - Seeking Alpha

Logistics of Vaccine Distribution Challenging: Cryoport CEO

YouTube video

Dec.01 -- Cryoport Inc. looks forward to the opportunity to participate in the distribution of the Covid-19 vaccines and admits the logistics will be challenging, Chief Executive Officer Jerrell Shelton...

5 months ago - Bloomberg Markets and Finance

Cryoport is a strong cold chain platform focused on the fast-growing cell and gene therapy end-market. Company has demonstrated strong execution through COVID and, with recent acquisitions, will become ...

5 months ago - Seeking Alpha

Cryoport's operating model remains insulated via key differentiators in the thermoregulatory logistics domain, with cloud-based integration along the audit chain. Linking with larger players in providin...

5 months ago - Seeking Alpha

Excited about the Covid-19 vaccines from Pfizer and Moderna? You'll be waiting a long time unless the vaccines can be shipped at 94 degrees below zero.

Other stocks mentioned: AVTR, MCK, TMO, UPS
5 months ago - Forbes

Cryoport, Inc. (CYRX) CEO Jerrell Shelton on Q3 2020 Results - Earnings Call Transcript

6 months ago - Seeking Alpha

NASHVILLE, Oct. 29, 2020 /PRNewswire/ -- Cryoport, Inc. (NASDAQ: CYRX) ("Cryoport" or the "Company"), a global leader in life sciences solutions, today announced that the Company will report financial r...

6 months ago - PRNewsWire

NASHVILLE, Tenn., Oct. 1, 2020 /PRNewswire/ -- Cryoport, Inc. (NASDAQ: CYRX) ("Cryoport" or the "Company"), the life sciences industry's preeminent partner for temperature-controlled supply chain soluti...

7 months ago - PRNewsWire

Final Trades: CrowdStrike, Cryoport, Industrials & more

YouTube video

The "Halftime Report" traders give their top picks to watch for the second half.

Other stocks mentioned: CRWD, LAMR, XLI
8 months ago - CNBC Television

How Cryoport plays a role in the coronavirus fight

YouTube video

CNBC's "Power Lunch" team talks about Cryoport's stock rally with Cryoport CEO Jerrell Shelton.

8 months ago - CNBC Television

Cryoport is acquiring Chart's cryobiological business and getting a big boost from one of the giants in private equity.

8 months ago - The Motley Fool

Cryoport (CYRX) saw a big move last session, as its shares jumped nearly 10% on the day, amid huge volumes.

8 months ago - Zacks Investment Research

NASHVILLE, Tenn., Aug. 25, 2020 /PRNewswire/ -- Cryoport, Inc.

8 months ago - PRNewsWire

NASHVILLE, Tenn., Aug. 21, 2020 /PRNewswire/ -- Cryoport, Inc.

8 months ago - PRNewsWire

Cryoport, Inc. (CYRX) CEO Jerrell Shelton on Q2 2020 Results - Earnings Call Transcript

9 months ago - Seeking Alpha

NASHVILLE, Tenn., Aug. 6, 2020 /PRNewswire/ -- Cryoport, Inc.

9 months ago - PRNewsWire

NASHVILLE, Tenn., Aug. 3, 2020 /PRNewswire/ -- Cryoport, Inc.

9 months ago - PRNewsWire

NASHVILLE, Tenn., May 21, 2020 /PRNewswire/ -- Cryoport, Inc. (NASDAQ: CYRX) ("Cryoport") today announced the pricing on May 20, 2020 of its offering of $100.0 million in aggregate principal amount of 3...

11 months ago - PRNewsWire

NASHVILLE, Tenn., May 19, 2020 /PRNewswire/ -- Cryoport, Inc. (NASDAQ: CYRX) ("Cryoport") today announced its intention to offer, subject to market and other conditions, $100.0 million in aggregate prin...

11 months ago - PRNewsWire

Cryoport, Inc. (CYRX) CEO Jerrell Shelton on Q1 2020 Results - Earnings Call Transcript

11 months ago - Seeking Alpha

Cryoport, Inc. (CYRX) CEO Jerrell Shelton on Q4 2019 Results - Earnings Call Transcript

1 year ago - Seeking Alpha

CryoPort: Profiting From CAR-T

1 year ago - Seeking Alpha

Buckle up, shareholders, and prepare for a miss in Q4.

1 year ago - The Motley Fool

Cryoport: Cold Chain Is A Hot Business Model

1 year ago - Seeking Alpha

Cryoport, Inc. (CYRX) CEO Jerrell Shelton on Q3 2019 Results - Earnings Call Transcript

1 year ago - Seeking Alpha

Cryoport's (CYRX) CEO Jerry Shelton on Q2 2019 Results - Earnings Call Transcript

1 year ago - Seeking Alpha

Both companies operate in the same market and are of similar size and produce comparable growth rates, yet CryoPort sells at 2.5x the valuation of BioLife.

Other stocks mentioned: BLFS
1 year ago - Seeking Alpha

Chimeric Antigen Receptor/T-Cell Receptor (CAR-T) is powering a fundamental shift for treating deadly cancers.

2 years ago - Seeking Alpha

Cryoport's (CYRX) CEO Jerry Shelton on Q1 2019 Results - Earnings Call Transcript

2 years ago - Seeking Alpha

CYRX earnings call for the period ending December 31, 2018.

2 years ago - The Motley Fool

About CYRX

Cryoport, Inc., a life sciences services company, provides temperature-controlled logistics solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers Cryoportal, a cloud-based logistics management platform that supports the management of shipments, which includes order entry, document preparation, customs documentation, courier management, real-time shipment tracking and monitoring, issue resolution, and regulatory compliance requirements; and CryoPort Express Shippers, which is used to ensure that the... [Read more...]

Industry
Integrated Freight & Logistics
Founded
1999
Stock Exchange
NASDAQ
Ticker Symbol
CYRX
Full Company Profile

Financial Performance

In 2020, CryoPort's revenue was $78.70 million, an increase of 131.85% compared to the previous year's $33.94 million. Losses were -$32.69 million, 78.3% more than in 2019.

Financial Statements

Analyst Forecasts

According to 6 analysts, the average rating for CryoPort stock is "Strong Buy." The 12-month stock price forecast is 76.13, which is an increase of 20.78% from the latest price.

Price Target
$76.13
(20.78% upside)
Analyst Consensus: Strong Buy